Skye Bioscience, Inc. — Director's Dealing 2014

Dec 17, 2014

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Nemus Bioscience, Inc. (NMUS)
CIK: 0001516551
Period of Report: 2014-12-10

Reporting Person: Ladin Brian D (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	299589	Indirect
Common Stock	465862	Indirect
Common Stock	329228	Indirect

Footnotes

F1: Mr. Ladin disclaims beneficial ownership of any securities reported herein except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of such shares for purposes of Section 16 or for any other purpose.

F2: Represents shares of common stock, no par value (the "Common Stock") of Nemus Bioscience, Inc. directly beneficially owned by Southern Investments I LLC.

F3: Represents shares of Common Stock directly beneficially owned by TC Global Management LLC.

F4: Represents shares of Common Stock directly beneficially owned by BRL TX- Family LP.